AASLD: New HCV Drug Promising, Cuts Out Interferon (CME/CE)

(MedPage Today) — SAN FRANCISCO -– Treatment with an investigational hepatitis C drug allowed investigators to dispense with an old stand-by — pegylated interferon-alpha.

Post a Comment

Comments are closed.